𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Down-regulation of Th1-mediated pathology in experimental arthritis by stimulation of the Th2 arm of the immune response

✍ Scribed by Claudia Mauri; Marc Feldmann; Richard O. Williams


Publisher
John Wiley and Sons
Year
2003
Tongue
English
Weight
88 KB
Volume
48
Category
Article
ISSN
0004-3591

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Objective

To assess whether systemic administration of recombinant interferon‐γ (rIFNγ), a proinflammatory cytokine that influences the differentiation of naive T cells into Th1 cells, promotes the induction of arthritis in DBA/1 mice immunized with type II collagen (CII) in Freund's incomplete adjuvant (IFA) and to determine the antiarthritic effect of treatment with CII in IFA.

Methods

DBA/1 mice were immunized with CII in IFA and injected intraperitoneally with rIFNγ (8,000 units/mouse/day) or with recombinant interleukin‐12 (rIL‐12; 100 ng/mouse/day). In another experiment, mice were immunized with CII in Freund's complete adjuvant (CFA) and treated with a single dose of CII in IFA on the day of immunization or on the day of disease onset. Mice were monitored to assess the effect of the treatment on the severity of disease. Th1/Th2 cytokines and anti‐CII antibodies were measured by enzyme‐linked immunosorbent assay.

Results

The administration of rIL‐12 or rIFNγ to mice immunized with CII in IFA restored the Th1 response and resulted in the development of arthritis. We then determined whether immunization with CII in IFA had the capacity to prevent and/or ameliorate collagen‐induced arthritis. A single intraperitoneal injection of CII in IFA prevented arthritis when given at the time of immunization with CII in CFA and reduced disease severity when given at the time of arthritis onset. The administration of CII in IFA resulted in a profound down‐regulation of IFNγ production and an up‐regulation of IL‐10 in cultures of draining lymph node cells.

Conclusion

These findings demonstrate that it is possible to deflect an ongoing pathogenic Th1 response to an antigen by reimmunization of the same antigen with a Th2‐polarizing adjuvant.


📜 SIMILAR VOLUMES


The role of IL-12 in the maintenance of
✍ Cris S. Constantinescu; Brian D. Hondowicz; M. Merle Elloso; Maria Wysocka; Gior 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 116 KB 👁 2 views

IL-12 initiates the development of cell-mediated immunity by promoting the differentiation of naive T cells into the Th1 phenotype, and is essential in the development of a Th1 immune response to the intracellular protozoan parasite, Leishmania major. The present study investigated whether IL-12 is

Indoleamine 2,3 dioxygenase–mediated try
✍ Gabriel Criado; Egle Šimelyte; Julia J. Inglis; David Essex; Richard O. Williams 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 171 KB

## Abstract ## Objective Indoleamine 2,3 dioxygenase (IDO) is a catabolic enzyme that initiates the kynurenine pathway of tryptophan degradation and has immunomodulatory properties. The aim of this study was to investigate the regulation of collagen‐induced arthritis by tryptophan catabolism media

Achievement of a synergistic adjuvant ef
✍ Anita Hanyecz; Suzanne E. Berlo; Sándor Szántó; Chris P. M. Broeren; Katalin Mik 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 367 KB 👁 2 views

## Abstract ## Objective To apply and analyze the mechanisms of action of dimethyldioctadecylammonium bromide (DDA), a powerful adjuvant that does not have the side effects of the conventionally used Freund's adjuvants, in proteoglycan‐induced arthritis (PGIA) and collagen‐induced arthritis (CIA).